Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Assets Average (2016 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Assets Average for 13 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 32.78% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Dec 2025, up 32.78%, and an annual FY2025 reading of $977.7 million, up 47.96% over the prior year.
  • Assets Average was $1.1 billion for Q4 2025 at Catalyst Pharmaceuticals, up from $1.0 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.1 billion in Q4 2025 and bottomed at $391.4 million in Q1 2023.
  • Average Assets Average over 3 years is $752.9 million, with a median of $775.4 million recorded in 2024.
  • The sharpest move saw Assets Average soared 83.79% in 2024, then surged 32.78% in 2025.
  • Year by year, Assets Average stood at $441.7 million in 2023, then surged by 83.79% to $811.7 million in 2024, then skyrocketed by 32.78% to $1.1 billion in 2025.
  • Business Quant data shows Assets Average for CPRX at $1.1 billion in Q4 2025, $1.0 billion in Q3 2025, and $940.4 million in Q2 2025.